Speech Entrainment for Aphasia
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Audiovisual Speech Entrainment Practice for aphasia?
Research shows that speech entrainment, where patients mimic an audiovisual speech model, significantly improves speech fluency in individuals with non-fluent aphasia, such as Broca's aphasia. Studies found that patients could produce a greater variety of words and improve speech output after using this treatment, suggesting it helps enhance speech production.12345
Is speech entrainment therapy safe for humans?
How is the treatment Speech Entrainment Therapy different from other treatments for aphasia?
Speech Entrainment Therapy is unique because it involves mimicking an audiovisual speech model, which helps improve speech fluency by synchronizing brain areas involved in language. This approach allows patients with non-fluent aphasia to produce more fluent speech compared to traditional methods, which often struggle to achieve such results.12357
What is the purpose of this trial?
The objective of this research is to experimentally delineate the direct effect of speech entrainment practice on independent speech production and identify practice conditions that enhance treatment benefits. The primary outcome measure (Correct Information Units per minute) tallies informativeness and efficiency of independent speech in treated stories.
Research Team
Marja-Liisa Mailend, PhD
Principal Investigator
Albert Einstein Healthcare Network
Eligibility Criteria
This trial is for English-speaking adults aged 18-80 with aphasia, which affects their ability to communicate. They must be more than six months post-onset and have a specific score on the Western Aphasia Battery - Revised test. Participants need to commit to multiple sessions either at the testing site or at home.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in speech entrainment practice, including auditory and audiovisual modalities, to enhance independent speech production.
Follow-up
Participants are monitored for speech production effectiveness one day post-treatment.
Treatment Details
Interventions
- Audiovisual Speech Entrainment Practice
- Auditory Speech Entrainment Practice
- Speech Entrainment Practice
Find a Clinic Near You
Who Is Running the Clinical Trial?
Albert Einstein Healthcare Network
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator